Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Candel Therapeutics (CADL) Asset Utilization Ratio (2021 - 2022)

Candel Therapeutics' Asset Utilization Ratio history spans 2 years, with the latest figure at 0.0 for Q4 2022.

  • On a quarterly basis, Asset Utilization Ratio rose 42.55% to 0.0 in Q4 2022 year-over-year; TTM through Dec 2022 was 0.0, a 42.55% increase, with the full-year FY2022 number at 0.0, down 4.52% from a year prior.
  • Asset Utilization Ratio hit 0.0 in Q4 2022 for Candel Therapeutics, up from 0.0 in the prior quarter.
  • Over the last five years, Asset Utilization Ratio for CADL hit a ceiling of 0.0 in Q3 2021 and a floor of 0.0 in Q2 2022.